共 36 条
Interleukin-24 attenuates β-glycerophosphate-induced calcification of vascular smooth muscle cells by inhibiting apoptosis, the expression of calcification and osteoblastic markers, and the Wnt/β-catenin pathway
被引:32
作者:
Lee, Ki-Mo
[1
]
Kang, Haeng-A.
[1
]
Park, Min
[1
]
Lee, Hwa-Youn
[1
]
Choi, Ha-Rim
[2
]
Yun, Chul-Ho
[1
]
Oh, Jae-Wook
[3
]
Kang, Hyung-Sik
[1
]
机构:
[1] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea
[2] Nambu Univ, Kwangju 506706, South Korea
[3] Konkuk Univ, Coll Anim Biosci & Technol, Div Anim Life Sci, Seoul 143701, South Korea
关键词:
Calcification;
Interleukin-24;
Calcification and osteoblastic markers;
Wnt/beta-catenin pathway;
PHOSPHATE-INDUCED CALCIFICATION;
IN-VITRO;
CANCER;
MINERALIZATION;
MECHANISMS;
MDA-7/IL-24;
PROTEINS;
STATINS;
D O I:
10.1016/j.bbrc.2012.09.145
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Vascular calcification is a hallmark of cardiovascular disease. Interleukin-24 (IL-24) has been known to suppress tumor progression in a variety of human cancers. However, the role of IL-24 in the pathophysiology of diseases other than cancer is unclear. We investigated the role of IL-24 in vascular calcification. IL-24 was applied to a p-glycerophosphate (beta-GP)-induced rat vascular smooth muscle cell (VSMC) calcification model. In this study, IL-24 significantly inhibited beta-GP-induced VSMC calcification, as determined by von Kossa staining and calcium content. The inhibitory effect of IL-24 on VSMC calcification was due to the suppression of beta-GP-induced apoptosis and expression of calcification and osteoblastic markers. In addition, IL-24 abrogated beta-GP-induced activation of the Wnt/beta-catenin pathway, which plays a key role in the pathogenesis of vascular calcification. The specificity of IL-24 for the inhibition of VSMC calcification was confirmed by using a neutralizing antibody to IL-24. Our results suggest that IL-24 inhibits beta-GP-induced VSMC calcification by inhibiting apoptosis, the expression of calcification and osteoblastic markers, and the Wnt/ beta-catenin pathway. Our study may provide a novel mechanism of action of IL-24 in cardiovascular disease and indicates that IL-24 is a potential therapeutic agent in VSMC calcification. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:50 / 55
页数:6
相关论文